Publications by authors named "Alberto Indacochea"

Claim this Profile
B
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.
Javier García-Corbacho, Alberto Indacochea, Iván Victoria, Débora Moreno, Laura Angelats

Cancer Immunol Immunother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Equitable Precision Oncology: Monitoring Racial and Ethnic Inclusion in Genomics and Clinical Trials.
Jennyfer M García-Cárdenas, Alberto Indacochea, David Pesantez-Coronel, Martín Terán-Navas, Ana Aleaga

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis.
Alberto Indacochea, Tanit Guitart, Aram Boada, Vicente Peg, Ariadna Quer

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis.
David Pesántez, Alberto Indacochea, Laura Angelats, Marianna Sirico, Iván Victoria

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas.
Jennyfer M García-Cárdenas, Isaac Armendáriz-Castillo, Nathali García-Cárdenas, David Pesantez-Coronel, Andrés López-Cortés, Alberto Indacochea

Front Cell Dev Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis.
Neus Mestre-Farràs, Santiago Guerrero, Nadine Bley, Ezequiel Rivero, Olga Coll, Alberto Indacochea

Nucleic Acids Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated In Silico Analyses Identify PUF60 and SF3A3 as New Spliceosome-Related Breast Cancer RNA-Binding Proteins.
Jennyfer M García-Cárdenas, Isaac Armendáriz-Castillo, Andy Pérez-Villa, Alberto Indacochea, Andrea Jácome-Alvarado

Biology (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Vicenç Ruiz de Porras, Xieng C Wang, Luis Palomero, Mercedes Marin-Aguilera, Carme Solé-Blanch, Alberto Indacochea

Eur Urol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels.
Alberto Indacochea, Santiago Guerrero, Macarena Ureña, Ferrán Araujo, Olga Coll

RNA· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quick guide for using Microsoft OneNote as an electronic laboratory notebook.
Santiago Guerrero, Andrés López-Cortés, Jennyfer M García-Cárdenas, Pablo Saa, Alberto Indacochea

PLoS Comput Biol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies.
Santiago Guerrero, Andrés López-Cortés, Alberto Indacochea, Jennyfer M García-Cárdenas, Ana Karina Zambrano

Sci Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Olatz Etxaniz, Cristina Carrato, Itziar de Aguirre, Cristina Queralt, Ana Muñoz, Alberto Indacochea

J Neurooncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Javier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Alberto Indacochea

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis and Implementation of an Electronic Laboratory Notebook in a Biomedical Research Institute.
Santiago Guerrero, Gwendal Dujardin, Alejandro Cabrera-Andrade, César Paz-Y-Miño, Alberto Indacochea

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome prognostic factors in inoperable malignant bowel obstruction.
Margarita Romeo, Maria de Los LLanos Gil, José Luís Cuadra Urteaga, Laia Vilà, Sara Ahlal, Alberto Indacochea

Support Care Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis